111 Total Liabilities and Share Holders Equity 2018-2024 | YI

111 total liabilities and share holders equity from 2018 to 2024. Total liabilities and share holders equity can be defined as the total of all liabilities and shareholders' equity.
111 Annual Total Liabilities and Share Holders Equity
(Millions of US $)
2023 $435
2022 $504
2021 $494
2020 $464
2019 $231
2018 $225
2017 $115
111 Quarterly Total Liabilities and Share Holders Equity
(Millions of US $)
2024-06-30 $384
2024-03-31 $405
2023-12-31 $435
2023-09-30 $461
2023-06-30 $421
2023-03-31 $472
2022-12-31 $504
2022-09-30 $429
2022-06-30 $463
2022-03-31 $475
2021-12-31 $494
2021-09-30 $486
2021-06-30 $511
2021-03-31 $470
2020-12-31 $464
2020-09-30 $401
2020-06-30 $267
2020-03-31 $233
2019-12-31 $231
2019-09-30 $234
2019-06-30 $253
2019-03-31 $239
2018-09-30 $247
2017-12-31 $115
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.051B $2.105B
111, Inc. operates as a digital and mobile healthcare platform. The Company offers pharmacy distribution, medical consultancy, e-prescription and other services. 111, Inc. is headquartered in Shanghai, China.
Stock Name Country Market Cap PE Ratio
GE HealthCare Technologies (GEHC) United States $40.428B 21.75
Tempus AI (TEM) United States $7.918B 0.00
Inspire Medical Systems (INSP) United States $6.215B 1157.72
Axonics (AXNX) United States $3.513B 0.00
Hims & Hers Health (HIMS) United States $3.503B 203.88
10x Genomics (TXG) United States $2.660B 0.00
Enovis (ENOV) United States $2.437B 17.67
Azenta (AZTA) United States $2.413B 137.03
Privia Health (PRVA) United States $2.280B 158.92
IRhythm Technologies (IRTC) United States $2.219B 0.00
Omnicell (OMCL) United States $1.968B 64.82
Clover Health Investments (CLOV) United States $1.492B 0.00
Schrodinger (SDGR) United States $1.436B 0.00
Phreesia (PHR) United States $1.389B 0.00
Standard BioTools (LAB) United States $0.753B 0.00
Fulgent Genetics (FLGT) United States $0.694B 0.00
Definitive Healthcare (DH) United States $0.538B 456.00
Health Catalyst (HCAT) United States $0.529B 0.00
Butterfly Network (BFLY) United States $0.406B 0.00
Talkspace (TALK) United States $0.343B 0.00
Pulmonx (LUNG) United States $0.329B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.286B 0.00
TruBridge (TBRG) United States $0.183B 13.44
P3 Health Partners (PIII) United States $0.165B 0.00
American Well (AMWL) United States $0.147B 0.00
Augmedix (AUGX) United States $0.115B 0.00
EUDA Health Holdings (EUDA) Singapore $0.090B 0.00
Future Health ESG (FHLT) United States $0.065B 0.00
SHL Telemedicine (SHLT) Israel $0.055B 0.00
HeartBeam (BEAT) United States $0.053B 0.00
Zepp Health (ZEPP) China $0.049B 0.00
CareCloud (CCLD) United States $0.045B 0.00
Movano (MOVE) United States $0.036B 0.00
Outset Medical (OM) United States $0.034B 0.00
MSP Recovery (LIFW) United States $0.025B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.024B 0.00
Bullfrog AI Holdings (BFRG) United States $0.018B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.018B 0.00
Strata Skin Sciences (SSKN) United States $0.012B 0.00
Streamline Health Solutions (STRM) United States $0.011B 0.00
Precipio (PRPO) United States $0.009B 0.00
Predictive Oncology (POAI) United States $0.006B 0.00
Zhongchao (ZCMD) China $0.003B 0.00
HeartSciences (HSCS) United States $0.003B 0.00
Syra Health (SYRA) United States $0.003B 0.00
Healthcare Triangle (HCTI) United States $0.002B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00